| 000 | 01749 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518084804.0 | ||
| 264 | 0 | _c20210826 | |
| 008 | 202108s 0 0 eng d | ||
| 022 | _a1432-1912 | ||
| 024 | 7 |
_a10.1007/s00210-020-01841-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWu, Yinyin | |
| 245 | 0 | 0 |
_a(-)-Epigallocatechin-3-gallate provides neuroprotection via AMPK activation against traumatic brain injury in a mouse model. _h[electronic resource] |
| 260 |
_bNaunyn-Schmiedeberg's archives of pharmacology _c11 2020 |
||
| 300 |
_a2209-2220 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAMP-Activated Protein Kinases _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 |
_aBrain Injuries, Traumatic _xdrug therapy |
| 650 | 0 | 4 |
_aCatechin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCerebral Cortex _xenzymology |
| 650 | 0 | 4 |
_aCognition _xdrug effects |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aMorris Water Maze Test _xdrug effects |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 | _aRotarod Performance Test |
| 650 | 0 | 4 | _aSignal Transduction |
| 700 | 1 | _aCui, Jing | |
| 773 | 0 |
_tNaunyn-Schmiedeberg's archives of pharmacology _gvol. 393 _gno. 11 _gp. 2209-2220 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00210-020-01841-1 _zAvailable from publisher's website |
| 999 |
_c30639135 _d30639135 |
||